Zhao Yan, Bai Yuansong, Li Mei, Nie Xin, Meng Hao, Shosei Shimizu, Liu Linlin, Yang Qingbiao, Shen Meili, Li Yapeng
Department of Medical Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130033, China.
Stroke center, Jilin Provincial Electric Power Hospital, Changchun, Jilin, 130022, China.
J Nanobiotechnology. 2024 Jul 16;22(1):420. doi: 10.1186/s12951-024-02677-0.
Triple negative breast cancer (TNBC) has the characteristics of low immune cell infiltration, high expression of tumor programmed death ligand 1 (PD-L1), and abundant cancer stem cells. Systemic toxicity of traditional chemotherapy drugs due to poor drug selectivity, and chemotherapy failure due to tumor drug resistance and other problems, so it is particularly important to find new cancer treatment strategies for TNBC with limited treatment options. Both the anti-tumor natural drugs curcumin and ginsenoside Rg3 can exert anti-tumor effects by inducing immunogenic cell death (ICD) of tumor cells, reducing PD-L1 expression, and reducing cancer stem cells. However, they have the disadvantages of poor water solubility, low bioavailability, and weak anti-tumor effect of single agents. We used vinyl ether bonds to link curcumin (Cur) with N-O type zwitterionic polymers and at the same time encapsulated ginsenoside Rg3 to obtain hyperbranched zwitterionic drug-loaded micelles OPDEA-PGED-5HA@Cur@Rg3 (PPH@CR) with pH response. In vitro cell experiments and in vivo animal experiments have proved that PPH@CR could not only promote the maturation of dendritic cells (DCs) and increase the CD4 T cells and CD8 T cells by inducing ICD in tumor cells but also reduce the expression of PD-L1 in tumor tissues, and reduce cancer stem cells and showed better anti-tumor effects and good biological safety compared with free double drugs, which is a promising cancer treatment strategy.
三阴性乳腺癌(TNBC)具有免疫细胞浸润少、肿瘤程序性死亡配体1(PD-L1)高表达和癌症干细胞丰富的特点。传统化疗药物由于药物选择性差而存在全身毒性,且因肿瘤耐药等问题导致化疗失败,因此针对治疗选择有限的TNBC寻找新的癌症治疗策略尤为重要。抗肿瘤天然药物姜黄素和人参皂苷Rg3均可通过诱导肿瘤细胞的免疫原性细胞死亡(ICD)、降低PD-L1表达以及减少癌症干细胞来发挥抗肿瘤作用。然而,它们存在水溶性差、生物利用度低以及单药抗肿瘤作用弱等缺点。我们利用乙烯醚键将姜黄素(Cur)与N-O型两性离子聚合物连接,同时包封人参皂苷Rg3,得到具有pH响应性的超支化两性离子载药胶束OPDEA-PGED-5HA@Cur@Rg3(PPH@CR)。体外细胞实验和体内动物实验证明,PPH@CR不仅可以通过诱导肿瘤细胞的ICD促进树突状细胞(DCs)成熟并增加CD4 T细胞和CD8 T细胞,还能降低肿瘤组织中PD-L1的表达,减少癌症干细胞,与游离双药相比显示出更好的抗肿瘤效果和良好的生物安全性,是一种有前景的癌症治疗策略。